Dilip Shanghvi, Sun Pharma founder
Sun Pharma shelling out $485M to settle US antitrust case against generics giant
Sun Pharma has agreed to a big payout to settle claims of misconduct leveled against its Ranbaxy generics unit.
Just ahead of a trial over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
